Brief: Biorestorative Therapies Says Topline Phase 2 Data For BRTX-100 Expected In Q2 2027
26/05/2026 16:28
BRIEF-Biorestorative Therapies Says Topline Phase 2 Data For BRTX-100 Expected In Q2 2027 May 26 (Reuters) - BioRestorative Therapies Inc BRTX.O:
BIORESTORATIVE THERAPIES INC - TOPLINE PHASE 2 DATA FOR BRTX-100 EXPECTED IN Q2 2027
Source text: ID:nGNX8Zh8Dv
Further company coverage: BRTX.O
((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM